Navigation Links
Bad Reaction No Good Reason to Avoid Future Shots
Date:10/15/2009

Experts urge doctors to investigate source of vaccine allergy,,

THURSDAY, Oct. 15 (HealthDay News) -- People who appear to be allergic to vaccinations shouldn't automatically avoid future immunizations, but instead should try to find out why they had a bad reaction, new guidelines say.

"Local, injection-site reactions and constitutional symptoms, especially fever, are common after vaccinations and do not contraindicate future doses," Dr. John M. Kelso, of the Division of Allergy, Asthma & Immunology at Scripps Clinic in San Diego, Calif., and a chief editor of the guidelines, explained in a news release from the American College of Allergy, Asthma & Immunology.

The guidelines are published in the October issue of Annals of Allergy, Asthma & Immunology.

An estimated 235 million vaccine doses are administered in the United States each year, and only about 235 people suffer a serious allergic reaction known as anaphylaxis, according to background information from the college. Deaths are extremely rare.

Kelso and his colleagues suggest that medical officials report all serious reactions to the Vaccine Adverse Event Reporting System so that experts can try to figure out what caused the reaction.

The guideline authors also recommend that allergists investigate allergic reactions and perform allergy testing to determine the cause and best treatment.

According to the researchers, the active ingredients within vaccines don't typically cause allergic reactions. Instead, sickness usually stems from other components, such as gelatin, egg protein and, more rarely, yeast, neomycin and thimerosal, as well as latex in immunization equipment.

"Gelatin, which is added to many vaccines as a stabilizer, is either bovine or porcine, which are extensively cross-reactive," Kelso said. "We recommend that a history of allergy to the ingestion of gelatin should be sought before administering a gelatin-containing vaccine."

"The MMR [measles, mumps, rubella vaccines] and one type of rabies vaccine contain negligible or no egg protein and can be administered to egg-allergic children without prior skin testing," he added. "Egg protein is present in higher amounts in yellow fever and influenza vaccines and may cause reactions in egg-allergic patients, who should be evaluated by an allergist prior to receiving these vaccines."

"However rare, if a patient gives a history of an immediate-type reaction to yeast, latex, neomycin or thimerosal, we recommend that it be investigated with skin testing before immunization with a vaccine containing these constituents," he said.

More information

The U.S. Centers for Disease Control and Prevention has more about vaccines and immunizations.



-- Randy Dotinga



SOURCE: American College of Allergy, Asthma & Immunology, news release, Oct. 8, 2009


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Despite ongoing safety concerns, study finds adverse reactions from contrast agents rarely occur
2. AMA Reaction to President Obamas Address on Health-System Reform
3. Research Firm will Obtain Americans Reactions to the Presidents Speech on Health Care Reform
4. New microchip technology performs 1,000 chemical reactions at once
5. Enigma Diagnostics Announces Patent On Real-Time Monitoring of Amplification Reactions Upheld In Entirety Following Opposition From BD at European Patent Office
6. Frost & Sullivan: Global Government Reactions to Swine Flu Is Key
7. Immune reaction to metal debris leads to early failure of joint implants
8. Take Action, Prevent Reactions at FAANs Annual Food Allergy Conferences
9. Bio-Reaction Industries Recognized as Leader in Technology
10. Drug Impedes Bodys Deadly Reaction to Flu Virus
11. TPHAC Reaction to Economic Impact Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/24/2017)... ... January 24, 2017 , ... OMI Industries, ... officially formed a distribution partnership with Byers Scientific & Manufacturing , a ... , Through the agreement, OMI Industries formulated a special version of Ecosorb® for ...
(Date:1/24/2017)... ... January 24, 2017 , ... Center for Hispanic Leadership (CHL) ... named Hector M. Chavez, Manager, Employee & Labor Relations at City of Hope ... Hispanic Leader of the Month. City of Hope is committed to stay out in ...
(Date:1/24/2017)... ... January 24, 2017 , ... The University of Iowa, ... great care to design a program that provides teachers with the specific skills and ... online teaching certificate is ideal for post-baccalaureate students and HigherEducation.com is working to ensure ...
(Date:1/24/2017)... ... January 24, 2017 , ... The NewKILO JRP, a three-year project of the ... the European Union (EU), was completed in May 2015. The future definition will require ... used in air, which presents some challenges to establishing traceability to the mass scale. ...
(Date:1/24/2017)... ... January 24, 2017 , ... Today, Taza Agua, Costa ... bottles, designed specifically to optimize the drinking experience for K-Cup coffee, tea and ... introducing the world’s first untouched bottled water purposed exclusively for creating a superior ...
Breaking Medicine News(10 mins):
(Date:1/24/2017)... GERMANTOWN, Md. , and GAITHERSBURG, Md. ... XON ), a leader in the engineering and ... health of the planet, today announced that it has entered ... (NASDAQ: GNVC ), a clinical-stage company and pioneer ... Intrexon intends to integrate and expand upon GenVec,s expertise ...
(Date:1/24/2017)... , January 24, 2017 www.Financialbuzz.com ... growing industries in the United States ... in 2016. In addition, Proposition 64, the California Cannabis Legalization ... 42.87% against on November 8, 2016. This outcome means that ... use and to grow a certain amount of cannabis for ...
(Date:1/24/2017)...   QR Pharma , Inc., a privately ... for the treatment of Alzheimer,s, Parkinson,s and other ... world-class key opinion leaders to its Scientific Advisory ... previous roster of impressive advisors in order to ... development of the breakthrough mechanism of action of ...
Breaking Medicine Technology: